Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s footer revision label has been incremented from v3.5.2 to v3.5.3, indicating a minor software/UI update rather than a change to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-25T06:14:30.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:53:21.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Publications section updated: replaced the 2025 online-ahead-of-print citation with the 2026 J Thorac Oncol article by Chen MF et al.
    Difference
    0.1%
    Check dated 2026-04-03T18:56:29.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-20T05:21:52.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The bottom revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:38:39.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a new publication citation for Chen MF et al., Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases. J Thorac Oncol. 2025 Oct 23:103505. Removed the earlier print-entry citation (S1556-0864(25)02859-X) in PubMed publications.
    Difference
    0.1%
    Check dated 2026-02-26T15:15:07.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.